Foot and Mouth Disease (FMD) vaccines are vaccines that provide active acquired immunity to Foot and Mouth Disease (FMD). Foot and Mouth Disease (FMD) is a highly contagious viral disease that primarily affects cloven-hooved livestock and wildlife like cattle, pigs, sheep and goats.
LPI (LP Information)' newest research report, the "Foot and Mouth Disease Vaccines Industry Forecast" looks at past sales and reviews total world Foot and Mouth Disease Vaccines sales in 2022, providing a comprehensive analysis by region and market sector of projected Foot and Mouth Disease Vaccines sales for 2023 through 2029. With Foot and Mouth Disease Vaccines sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Foot and Mouth Disease Vaccines industry.
This Insight Report provides a comprehensive analysis of the global Foot and Mouth Disease Vaccines landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Foot and Mouth Disease Vaccines portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Foot and Mouth Disease Vaccines market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Foot and Mouth Disease Vaccines and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Foot and Mouth Disease Vaccines.
The global Foot and Mouth Disease Vaccines market size is projected to grow from US$ 1023.2 million in 2022 to US$ 1322.7 million in 2029; it is expected to grow at a CAGR of 1322.7 from 2023 to 2029.
Global Foot and Mouth Disease (FMD) Vaccines key players include Jinyu Group, Indian Immunologicals, Tecon Group, CAHIC, etc. Global top four manufacturers hold a share nearly 60%.
Asia-Pacific is the largest market, with a share about 80%, followed by Central & South America, and Europe, both have a share over 15 percent.
In terms of product, Conventional Vaccines is the largest segment, with a share about 70%. And in terms of application, the largest application is Cattle, followed by Pig, Sheep and Goat , etc.
This report presents a comprehensive overview, market shares, and growth opportunities of Foot and Mouth Disease Vaccines market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
- Emergency Vaccines
- Conventional Vaccines
Segmentation by application
- Cattle
- Pig
- Sheep & Goat
- Other
This report also splits the market by region:
- Americas
- - United States
- - Canada
- - Mexico
- - Brazil
- APAC
- - China
- - Japan
- - Korea
- - Southeast Asia
- - India
- - Australia
- Europe
- - Germany
- - France
- - UK
- - Italy
- - Russia
- Middle East & Africa
- - Egypt
- - South Africa
- - Israel
- - Turkey
- - GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
- Jinyu Group
- Cavet Bio
- CAHIC
- Tecon Group
- Shen Lian
- Biogenesis Bago
- BIGVET Biotech
- Indian Immunologicals
- Boehringer Ingelheim
- MSD Animal Health
- CEVA
- Bayer HealthCare
- VECOL
- Sanofi (Merial)
- Brilliant Bio Pharma
- VETAL
- BVI
- LIMOR
- ME VAC
- Agrovet
Key Questions Addressed in this Report
What is the 10-year outlook for the global Foot and Mouth Disease Vaccines market?
What factors are driving Foot and Mouth Disease Vaccines market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Foot and Mouth Disease Vaccines market opportunities vary by end market size?
How does Foot and Mouth Disease Vaccines break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
Global Foot and Mouth Disease Vaccines Market Growth 2023-2029
Table of Contents
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Foot and Mouth Disease Vaccines Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Foot and Mouth Disease Vaccines by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Foot and Mouth Disease Vaccines by Country/Region, 2018, 2022 & 2029
2.2 Foot and Mouth Disease Vaccines Segment by Type
2.2.1 Emergency Vaccines
2.2.2 Conventional Vaccines
2.3 Foot and Mouth Disease Vaccines Sales by Type
2.3.1 Global Foot and Mouth Disease Vaccines Sales Market Share by Type (2018-2023)
2.3.2 Global Foot and Mouth Disease Vaccines Revenue and Market Share by Type (2018-2023)
2.3.3 Global Foot and Mouth Disease Vaccines Sale Price by Type (2018-2023)
2.4 Foot and Mouth Disease Vaccines Segment by Application
2.4.1 Cattle
2.4.2 Pig
2.4.3 Sheep & Goat
2.4.4 Other
2.5 Foot and Mouth Disease Vaccines Sales by Application
2.5.1 Global Foot and Mouth Disease Vaccines Sale Market Share by Application (2018-2023)
2.5.2 Global Foot and Mouth Disease Vaccines Revenue and Market Share by Application (2018-2023)
2.5.3 Global Foot and Mouth Disease Vaccines Sale Price by Application (2018-2023)
3 Global Foot and Mouth Disease Vaccines by Company
3.1 Global Foot and Mouth Disease Vaccines Breakdown Data by Company
3.1.1 Global Foot and Mouth Disease Vaccines Annual Sales by Company (2018-2023)
3.1.2 Global Foot and Mouth Disease Vaccines Sales Market Share by Company (2018-2023)
3.2 Global Foot and Mouth Disease Vaccines Annual Revenue by Company (2018-2023)
3.2.1 Global Foot and Mouth Disease Vaccines Revenue by Company (2018-2023)
3.2.2 Global Foot and Mouth Disease Vaccines Revenue Market Share by Company (2018-2023)
3.3 Global Foot and Mouth Disease Vaccines Sale Price by Company
3.4 Key Manufacturers Foot and Mouth Disease Vaccines Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Foot and Mouth Disease Vaccines Product Location Distribution
3.4.2 Players Foot and Mouth Disease Vaccines Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Foot and Mouth Disease Vaccines by Geographic Region
4.1 World Historic Foot and Mouth Disease Vaccines Market Size by Geographic Region (2018-2023)
4.1.1 Global Foot and Mouth Disease Vaccines Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Foot and Mouth Disease Vaccines Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Foot and Mouth Disease Vaccines Market Size by Country/Region (2018-2023)
4.2.1 Global Foot and Mouth Disease Vaccines Annual Sales by Country/Region (2018-2023)
4.2.2 Global Foot and Mouth Disease Vaccines Annual Revenue by Country/Region (2018-2023)
4.3 Americas Foot and Mouth Disease Vaccines Sales Growth
4.4 APAC Foot and Mouth Disease Vaccines Sales Growth
4.5 Europe Foot and Mouth Disease Vaccines Sales Growth
4.6 Middle East & Africa Foot and Mouth Disease Vaccines Sales Growth
5 Americas
5.1 Americas Foot and Mouth Disease Vaccines Sales by Country
5.1.1 Americas Foot and Mouth Disease Vaccines Sales by Country (2018-2023)
5.1.2 Americas Foot and Mouth Disease Vaccines Revenue by Country (2018-2023)
5.2 Americas Foot and Mouth Disease Vaccines Sales by Type
5.3 Americas Foot and Mouth Disease Vaccines Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Foot and Mouth Disease Vaccines Sales by Region
6.1.1 APAC Foot and Mouth Disease Vaccines Sales by Region (2018-2023)
6.1.2 APAC Foot and Mouth Disease Vaccines Revenue by Region (2018-2023)
6.2 APAC Foot and Mouth Disease Vaccines Sales by Type
6.3 APAC Foot and Mouth Disease Vaccines Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Foot and Mouth Disease Vaccines by Country
7.1.1 Europe Foot and Mouth Disease Vaccines Sales by Country (2018-2023)
7.1.2 Europe Foot and Mouth Disease Vaccines Revenue by Country (2018-2023)
7.2 Europe Foot and Mouth Disease Vaccines Sales by Type
7.3 Europe Foot and Mouth Disease Vaccines Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Foot and Mouth Disease Vaccines by Country
8.1.1 Middle East & Africa Foot and Mouth Disease Vaccines Sales by Country (2018-2023)
8.1.2 Middle East & Africa Foot and Mouth Disease Vaccines Revenue by Country (2018-2023)
8.2 Middle East & Africa Foot and Mouth Disease Vaccines Sales by Type
8.3 Middle East & Africa Foot and Mouth Disease Vaccines Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Foot and Mouth Disease Vaccines
10.3 Manufacturing Process Analysis of Foot and Mouth Disease Vaccines
10.4 Industry Chain Structure of Foot and Mouth Disease Vaccines
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Foot and Mouth Disease Vaccines Distributors
11.3 Foot and Mouth Disease Vaccines Customer
12 World Forecast Review for Foot and Mouth Disease Vaccines by Geographic Region
12.1 Global Foot and Mouth Disease Vaccines Market Size Forecast by Region
12.1.1 Global Foot and Mouth Disease Vaccines Forecast by Region (2024-2029)
12.1.2 Global Foot and Mouth Disease Vaccines Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Foot and Mouth Disease Vaccines Forecast by Type
12.7 Global Foot and Mouth Disease Vaccines Forecast by Application
13 Key Players Analysis
13.1 Jinyu Group
13.1.1 Jinyu Group Company Information
13.1.2 Jinyu Group Foot and Mouth Disease Vaccines Product Portfolios and Specifications
13.1.3 Jinyu Group Foot and Mouth Disease Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Jinyu Group Main Business Overview
13.1.5 Jinyu Group Latest Developments
13.2 Cavet Bio
13.2.1 Cavet Bio Company Information
13.2.2 Cavet Bio Foot and Mouth Disease Vaccines Product Portfolios and Specifications
13.2.3 Cavet Bio Foot and Mouth Disease Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Cavet Bio Main Business Overview
13.2.5 Cavet Bio Latest Developments
13.3 CAHIC
13.3.1 CAHIC Company Information
13.3.2 CAHIC Foot and Mouth Disease Vaccines Product Portfolios and Specifications
13.3.3 CAHIC Foot and Mouth Disease Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 CAHIC Main Business Overview
13.3.5 CAHIC Latest Developments
13.4 Tecon Group
13.4.1 Tecon Group Company Information
13.4.2 Tecon Group Foot and Mouth Disease Vaccines Product Portfolios and Specifications
13.4.3 Tecon Group Foot and Mouth Disease Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Tecon Group Main Business Overview
13.4.5 Tecon Group Latest Developments
13.5 Shen Lian
13.5.1 Shen Lian Company Information
13.5.2 Shen Lian Foot and Mouth Disease Vaccines Product Portfolios and Specifications
13.5.3 Shen Lian Foot and Mouth Disease Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Shen Lian Main Business Overview
13.5.5 Shen Lian Latest Developments
13.6 Biogenesis Bago
13.6.1 Biogenesis Bago Company Information
13.6.2 Biogenesis Bago Foot and Mouth Disease Vaccines Product Portfolios and Specifications
13.6.3 Biogenesis Bago Foot and Mouth Disease Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Biogenesis Bago Main Business Overview
13.6.5 Biogenesis Bago Latest Developments
13.7 BIGVET Biotech
13.7.1 BIGVET Biotech Company Information
13.7.2 BIGVET Biotech Foot and Mouth Disease Vaccines Product Portfolios and Specifications
13.7.3 BIGVET Biotech Foot and Mouth Disease Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 BIGVET Biotech Main Business Overview
13.7.5 BIGVET Biotech Latest Developments
13.8 Indian Immunologicals
13.8.1 Indian Immunologicals Company Information
13.8.2 Indian Immunologicals Foot and Mouth Disease Vaccines Product Portfolios and Specifications
13.8.3 Indian Immunologicals Foot and Mouth Disease Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Indian Immunologicals Main Business Overview
13.8.5 Indian Immunologicals Latest Developments
13.9 Boehringer Ingelheim
13.9.1 Boehringer Ingelheim Company Information
13.9.2 Boehringer Ingelheim Foot and Mouth Disease Vaccines Product Portfolios and Specifications
13.9.3 Boehringer Ingelheim Foot and Mouth Disease Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Boehringer Ingelheim Main Business Overview
13.9.5 Boehringer Ingelheim Latest Developments
13.10 MSD Animal Health
13.10.1 MSD Animal Health Company Information
13.10.2 MSD Animal Health Foot and Mouth Disease Vaccines Product Portfolios and Specifications
13.10.3 MSD Animal Health Foot and Mouth Disease Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 MSD Animal Health Main Business Overview
13.10.5 MSD Animal Health Latest Developments
13.11 CEVA
13.11.1 CEVA Company Information
13.11.2 CEVA Foot and Mouth Disease Vaccines Product Portfolios and Specifications
13.11.3 CEVA Foot and Mouth Disease Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 CEVA Main Business Overview
13.11.5 CEVA Latest Developments
13.12 Bayer HealthCare
13.12.1 Bayer HealthCare Company Information
13.12.2 Bayer HealthCare Foot and Mouth Disease Vaccines Product Portfolios and Specifications
13.12.3 Bayer HealthCare Foot and Mouth Disease Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.12.4 Bayer HealthCare Main Business Overview
13.12.5 Bayer HealthCare Latest Developments
13.13 VECOL
13.13.1 VECOL Company Information
13.13.2 VECOL Foot and Mouth Disease Vaccines Product Portfolios and Specifications
13.13.3 VECOL Foot and Mouth Disease Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.13.4 VECOL Main Business Overview
13.13.5 VECOL Latest Developments
13.14 Sanofi (Merial)
13.14.1 Sanofi (Merial) Company Information
13.14.2 Sanofi (Merial) Foot and Mouth Disease Vaccines Product Portfolios and Specifications
13.14.3 Sanofi (Merial) Foot and Mouth Disease Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.14.4 Sanofi (Merial) Main Business Overview
13.14.5 Sanofi (Merial) Latest Developments
13.15 Brilliant Bio Pharma
13.15.1 Brilliant Bio Pharma Company Information
13.15.2 Brilliant Bio Pharma Foot and Mouth Disease Vaccines Product Portfolios and Specifications
13.15.3 Brilliant Bio Pharma Foot and Mouth Disease Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.15.4 Brilliant Bio Pharma Main Business Overview
13.15.5 Brilliant Bio Pharma Latest Developments
13.16 VETAL
13.16.1 VETAL Company Information
13.16.2 VETAL Foot and Mouth Disease Vaccines Product Portfolios and Specifications
13.16.3 VETAL Foot and Mouth Disease Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.16.4 VETAL Main Business Overview
13.16.5 VETAL Latest Developments
13.17 BVI
13.17.1 BVI Company Information
13.17.2 BVI Foot and Mouth Disease Vaccines Product Portfolios and Specifications
13.17.3 BVI Foot and Mouth Disease Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.17.4 BVI Main Business Overview
13.17.5 BVI Latest Developments
13.18 LIMOR
13.18.1 LIMOR Company Information
13.18.2 LIMOR Foot and Mouth Disease Vaccines Product Portfolios and Specifications
13.18.3 LIMOR Foot and Mouth Disease Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.18.4 LIMOR Main Business Overview
13.18.5 LIMOR Latest Developments
13.19 ME VAC
13.19.1 ME VAC Company Information
13.19.2 ME VAC Foot and Mouth Disease Vaccines Product Portfolios and Specifications
13.19.3 ME VAC Foot and Mouth Disease Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.19.4 ME VAC Main Business Overview
13.19.5 ME VAC Latest Developments
13.20 Agrovet
13.20.1 Agrovet Company Information
13.20.2 Agrovet Foot and Mouth Disease Vaccines Product Portfolios and Specifications
13.20.3 Agrovet Foot and Mouth Disease Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.20.4 Agrovet Main Business Overview
13.20.5 Agrovet Latest Developments
14 Research Findings and Conclusion
List of Tables
Table 1. Foot and Mouth Disease Vaccines Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Foot and Mouth Disease Vaccines Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Emergency Vaccines
Table 4. Major Players of Conventional Vaccines
Table 5. Global Foot and Mouth Disease Vaccines Sales by Type (2018-2023) & (K L)
Table 6. Global Foot and Mouth Disease Vaccines Sales Market Share by Type (2018-2023)
Table 7. Global Foot and Mouth Disease Vaccines Revenue by Type (2018-2023) & ($ million)
Table 8. Global Foot and Mouth Disease Vaccines Revenue Market Share by Type (2018-2023)
Table 9. Global Foot and Mouth Disease Vaccines Sale Price by Type (2018-2023) & (USD/L)
Table 10. Global Foot and Mouth Disease Vaccines Sales by Application (2018-2023) & (K L)
Table 11. Global Foot and Mouth Disease Vaccines Sales Market Share by Application (2018-2023)
Table 12. Global Foot and Mouth Disease Vaccines Revenue by Application (2018-2023)
Table 13. Global Foot and Mouth Disease Vaccines Revenue Market Share by Application (2018-2023)
Table 14. Global Foot and Mouth Disease Vaccines Sale Price by Application (2018-2023) & (USD/L)
Table 15. Global Foot and Mouth Disease Vaccines Sales by Company (2018-2023) & (K L)
Table 16. Global Foot and Mouth Disease Vaccines Sales Market Share by Company (2018-2023)
Table 17. Global Foot and Mouth Disease Vaccines Revenue by Company (2018-2023) ($ Millions)
Table 18. Global Foot and Mouth Disease Vaccines Revenue Market Share by Company (2018-2023)
Table 19. Global Foot and Mouth Disease Vaccines Sale Price by Company (2018-2023) & (USD/L)
Table 20. Key Manufacturers Foot and Mouth Disease Vaccines Producing Area Distribution and Sales Area
Table 21. Players Foot and Mouth Disease Vaccines Products Offered
Table 22. Foot and Mouth Disease Vaccines Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Foot and Mouth Disease Vaccines Sales by Geographic Region (2018-2023) & (K L)
Table 26. Global Foot and Mouth Disease Vaccines Sales Market Share Geographic Region (2018-2023)
Table 27. Global Foot and Mouth Disease Vaccines Revenue by Geographic Region (2018-2023) & ($ millions)
Table 28. Global Foot and Mouth Disease Vaccines Revenue Market Share by Geographic Region (2018-2023)
Table 29. Global Foot and Mouth Disease Vaccines Sales by Country/Region (2018-2023) & (K L)
Table 30. Global Foot and Mouth Disease Vaccines Sales Market Share by Country/Region (2018-2023)
Table 31. Global Foot and Mouth Disease Vaccines Revenue by Country/Region (2018-2023) & ($ millions)
Table 32. Global Foot and Mouth Disease Vaccines Revenue Market Share by Country/Region (2018-2023)
Table 33. Americas Foot and Mouth Disease Vaccines Sales by Country (2018-2023) & (K L)
Table 34. Americas Foot and Mouth Disease Vaccines Sales Market Share by Country (2018-2023)
Table 35. Americas Foot and Mouth Disease Vaccines Revenue by Country (2018-2023) & ($ Millions)
Table 36. Americas Foot and Mouth Disease Vaccines Revenue Market Share by Country (2018-2023)
Table 37. Americas Foot and Mouth Disease Vaccines Sales by Type (2018-2023) & (K L)
Table 38. Americas Foot and Mouth Disease Vaccines Sales by Application (2018-2023) & (K L)
Table 39. APAC Foot and Mouth Disease Vaccines Sales by Region (2018-2023) & (K L)
Table 40. APAC Foot and Mouth Disease Vaccines Sales Market Share by Region (2018-2023)
Table 41. APAC Foot and Mouth Disease Vaccines Revenue by Region (2018-2023) & ($ Millions)
Table 42. APAC Foot and Mouth Disease Vaccines Revenue Market Share by Region (2018-2023)
Table 43. APAC Foot and Mouth Disease Vaccines Sales by Type (2018-2023) & (K L)
Table 44. APAC Foot and Mouth Disease Vaccines Sales by Application (2018-2023) & (K L)
Table 45. Europe Foot and Mouth Disease Vaccines Sales by Country (2018-2023) & (K L)
Table 46. Europe Foot and Mouth Disease Vaccines Sales Market Share by Country (2018-2023)
Table 47. Europe Foot and Mouth Disease Vaccines Revenue by Country (2018-2023) & ($ Millions)
Table 48. Europe Foot and Mouth Disease Vaccines Revenue Market Share by Country (2018-2023)
Table 49. Europe Foot and Mouth Disease Vaccines Sales by Type (2018-2023) & (K L)
Table 50. Europe Foot and Mouth Disease Vaccines Sales by Application (2018-2023) & (K L)
Table 51. Middle East & Africa Foot and Mouth Disease Vaccines Sales by Country (2018-2023) & (K L)
Table 52. Middle East & Africa Foot and Mouth Disease Vaccines Sales Market Share by Country (2018-2023)
Table 53. Middle East & Africa Foot and Mouth Disease Vaccines Revenue by Country (2018-2023) & ($ Millions)
Table 54. Middle East & Africa Foot and Mouth Disease Vaccines Revenue Market Share by Country (2018-2023)
Table 55. Middle East & Africa Foot and Mouth Disease Vaccines Sales by Type (2018-2023) & (K L)
Table 56. Middle East & Africa Foot and Mouth Disease Vaccines Sales by Application (2018-2023) & (K L)
Table 57. Key Market Drivers & Growth Opportunities of Foot and Mouth Disease Vaccines
Table 58. Key Market Challenges & Risks of Foot and Mouth Disease Vaccines
Table 59. Key Industry Trends of Foot and Mouth Disease Vaccines
Table 60. Foot and Mouth Disease Vaccines Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. Foot and Mouth Disease Vaccines Distributors List
Table 63. Foot and Mouth Disease Vaccines Customer List
Table 64. Global Foot and Mouth Disease Vaccines Sales Forecast by Region (2024-2029) & (K L)
Table 65. Global Foot and Mouth Disease Vaccines Revenue Forecast by Region (2024-2029) & ($ millions)
Table 66. Americas Foot and Mouth Disease Vaccines Sales Forecast by Country (2024-2029) & (K L)
Table 67. Americas Foot and Mouth Disease Vaccines Revenue Forecast by Country (2024-2029) & ($ millions)
Table 68. APAC Foot and Mouth Disease Vaccines Sales Forecast by Region (2024-2029) & (K L)
Table 69. APAC Foot and Mouth Disease Vaccines Revenue Forecast by Region (2024-2029) & ($ millions)
Table 70. Europe Foot and Mouth Disease Vaccines Sales Forecast by Country (2024-2029) & (K L)
Table 71. Europe Foot and Mouth Disease Vaccines Revenue Forecast by Country (2024-2029) & ($ millions)
Table 72. Middle East & Africa Foot and Mouth Disease Vaccines Sales Forecast by Country (2024-2029) & (K L)
Table 73. Middle East & Africa Foot and Mouth Disease Vaccines Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Global Foot and Mouth Disease Vaccines Sales Forecast by Type (2024-2029) & (K L)
Table 75. Global Foot and Mouth Disease Vaccines Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 76. Global Foot and Mouth Disease Vaccines Sales Forecast by Application (2024-2029) & (K L)
Table 77. Global Foot and Mouth Disease Vaccines Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 78. Jinyu Group Basic Information, Foot and Mouth Disease Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 79. Jinyu Group Foot and Mouth Disease Vaccines Product Portfolios and Specifications
Table 80. Jinyu Group Foot and Mouth Disease Vaccines Sales (K L), Revenue ($ Million), Price (USD/L) and Gross Margin (2018-2023)
Table 81. Jinyu Group Main Business
Table 82. Jinyu Group Latest Developments
Table 83. Cavet Bio Basic Information, Foot and Mouth Disease Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 84. Cavet Bio Foot and Mouth Disease Vaccines Product Portfolios and Specifications
Table 85. Cavet Bio Foot and Mouth Disease Vaccines Sales (K L), Revenue ($ Million), Price (USD/L) and Gross Margin (2018-2023)
Table 86. Cavet Bio Main Business
Table 87. Cavet Bio Latest Developments
Table 88. CAHIC Basic Information, Foot and Mouth Disease Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 89. CAHIC Foot and Mouth Disease Vaccines Product Portfolios and Specifications
Table 90. CAHIC Foot and Mouth Disease Vaccines Sales (K L), Revenue ($ Million), Price (USD/L) and Gross Margin (2018-2023)
Table 91. CAHIC Main Business
Table 92. CAHIC Latest Developments
Table 93. Tecon Group Basic Information, Foot and Mouth Disease Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 94. Tecon Group Foot and Mouth Disease Vaccines Product Portfolios and Specifications
Table 95. Tecon Group Foot and Mouth Disease Vaccines Sales (K L), Revenue ($ Million), Price (USD/L) and Gross Margin (2018-2023)
Table 96. Tecon Group Main Business
Table 97. Tecon Group Latest Developments
Table 98. Shen Lian Basic Information, Foot and Mouth Disease Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 99. Shen Lian Foot and Mouth Disease Vaccines Product Portfolios and Specifications
Table 100. Shen Lian Foot and Mouth Disease Vaccines Sales (K L), Revenue ($ Million), Price (USD/L) and Gross Margin (2018-2023)
Table 101. Shen Lian Main Business
Table 102. Shen Lian Latest Developments
Table 103. Biogenesis Bago Basic Information, Foot and Mouth Disease Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 104. Biogenesis Bago Foot and Mouth Disease Vaccines Product Portfolios and Specifications
Table 105. Biogenesis Bago Foot and Mouth Disease Vaccines Sales (K L), Revenue ($ Million), Price (USD/L) and Gross Margin (2018-2023)
Table 106. Biogenesis Bago Main Business
Table 107. Biogenesis Bago Latest Developments
Table 108. BIGVET Biotech Basic Information, Foot and Mouth Disease Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 109. BIGVET Biotech Foot and Mouth Disease Vaccines Product Portfolios and Specifications
Table 110. BIGVET Biotech Foot and Mouth Disease Vaccines Sales (K L), Revenue ($ Million), Price (USD/L) and Gross Margin (2018-2023)
Table 111. BIGVET Biotech Main Business
Table 112. BIGVET Biotech Latest Developments
Table 113. Indian Immunologicals Basic Information, Foot and Mouth Disease Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 114. Indian Immunologicals Foot and Mouth Disease Vaccines Product Portfolios and Specifications
Table 115. Indian Immunologicals Foot and Mouth Disease Vaccines Sales (K L), Revenue ($ Million), Price (USD/L) and Gross Margin (2018-2023)
Table 116. Indian Immunologicals Main Business
Table 117. Indian Immunologicals Latest Developments
Table 118. Boehringer Ingelheim Basic Information, Foot and Mouth Disease Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 119. Boehringer Ingelheim Foot and Mouth Disease Vaccines Product Portfolios and Specifications
Table 120. Boehringer Ingelheim Foot and Mouth Disease Vaccines Sales (K L), Revenue ($ Million), Price (USD/L) and Gross Margin (2018-2023)
Table 121. Boehringer Ingelheim Main Business
Table 122. Boehringer Ingelheim Latest Developments
Table 123. MSD Animal Health Basic Information, Foot and Mouth Disease Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 124. MSD Animal Health Foot and Mouth Disease Vaccines Product Portfolios and Specifications
Table 125. MSD Animal Health Foot and Mouth Disease Vaccines Sales (K L), Revenue ($ Million), Price (USD/L) and Gross Margin (2018-2023)
Table 126. MSD Animal Health Main Business
Table 127. MSD Animal Health Latest Developments
Table 128. CEVA Basic Information, Foot and Mouth Disease Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 129. CEVA Foot and Mouth Disease Vaccines Product Portfolios and Specifications
Table 130. CEVA Foot and Mouth Disease Vaccines Sales (K L), Revenue ($ Million), Price (USD/L) and Gross Margin (2018-2023)
Table 131. CEVA Main Business
Table 132. CEVA Latest Developments
Table 133. Bayer HealthCare Basic Information, Foot and Mouth Disease Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 134. Bayer HealthCare Foot and Mouth Disease Vaccines Product Portfolios and Specifications
Table 135. Bayer HealthCare Foot and Mouth Disease Vaccines Sales (K L), Revenue ($ Million), Price (USD/L) and Gross Margin (2018-2023)
Table 136. Bayer HealthCare Main Business
Table 137. Bayer HealthCare Latest Developments
Table 138. VECOL Basic Information, Foot and Mouth Disease Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 139. VECOL Foot and Mouth Disease Vaccines Product Portfolios and Specifications
Table 140. VECOL Foot and Mouth Disease Vaccines Sales (K L), Revenue ($ Million), Price (USD/L) and Gross Margin (2018-2023)
Table 141. VECOL Main Business
Table 142. VECOL Latest Developments
Table 143. Sanofi (Merial) Basic Information, Foot and Mouth Disease Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 144. Sanofi (Merial) Foot and Mouth Disease Vaccines Product Portfolios and Specifications
Table 145. Sanofi (Merial) Foot and Mouth Disease Vaccines Sales (K L), Revenue ($ Million), Price (USD/L) and Gross Margin (2018-2023)
Table 146. Sanofi (Merial) Main Business
Table 147. Sanofi (Merial) Latest Developments
Table 148. Brilliant Bio Pharma Basic Information, Foot and Mouth Disease Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 149. Brilliant Bio Pharma Foot and Mouth Disease Vaccines Product Portfolios and Specifications
Table 150. Brilliant Bio Pharma Foot and Mouth Disease Vaccines Sales (K L), Revenue ($ Million), Price (USD/L) and Gross Margin (2018-2023)
Table 151. Brilliant Bio Pharma Main Business
Table 152. Brilliant Bio Pharma Latest Developments
Table 153. VETAL Basic Information, Foot and Mouth Disease Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 154. VETAL Foot and Mouth Disease Vaccines Product Portfolios and Specifications
Table 155. VETAL Foot and Mouth Disease Vaccines Sales (K L), Revenue ($ Million), Price (USD/L) and Gross Margin (2018-2023)
Table 156. VETAL Main Business
Table 157. VETAL Latest Developments
Table 158. BVI Basic Information, Foot and Mouth Disease Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 159. BVI Foot and Mouth Disease Vaccines Product Portfolios and Specifications
Table 160. BVI Foot and Mouth Disease Vaccines Sales (K L), Revenue ($ Million), Price (USD/L) and Gross Margin (2018-2023)
Table 161. BVI Main Business
Table 162. BVI Latest Developments
Table 163. LIMOR Basic Information, Foot and Mouth Disease Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 164. LIMOR Foot and Mouth Disease Vaccines Product Portfolios and Specifications
Table 165. LIMOR Foot and Mouth Disease Vaccines Sales (K L), Revenue ($ Million), Price (USD/L) and Gross Margin (2018-2023)
Table 166. LIMOR Main Business
Table 167. LIMOR Latest Developments
Table 168. ME VAC Basic Information, Foot and Mouth Disease Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 169. ME VAC Foot and Mouth Disease Vaccines Product Portfolios and Specifications
Table 170. ME VAC Foot and Mouth Disease Vaccines Sales (K L), Revenue ($ Million), Price (USD/L) and Gross Margin (2018-2023)
Table 171. ME VAC Main Business
Table 172. ME VAC Latest Developments
Table 173. Agrovet Basic Information, Foot and Mouth Disease Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 174. Agrovet Foot and Mouth Disease Vaccines Product Portfolios and Specifications
Table 175. Agrovet Foot and Mouth Disease Vaccines Sales (K L), Revenue ($ Million), Price (USD/L) and Gross Margin (2018-2023)
Table 176. Agrovet Main Business
Table 177. Agrovet Latest Developments
List of Figures
Figure 1. Picture of Foot and Mouth Disease Vaccines
Figure 2. Foot and Mouth Disease Vaccines Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Foot and Mouth Disease Vaccines Sales Growth Rate 2018-2029 (K L)
Figure 7. Global Foot and Mouth Disease Vaccines Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Foot and Mouth Disease Vaccines Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Emergency Vaccines
Figure 10. Product Picture of Conventional Vaccines
Figure 11. Global Foot and Mouth Disease Vaccines Sales Market Share by Type in 2022
Figure 12. Global Foot and Mouth Disease Vaccines Revenue Market Share by Type (2018-2023)
Figure 13. Foot and Mouth Disease Vaccines Consumed in Cattle
Figure 14. Global Foot and Mouth Disease Vaccines Market: Cattle (2018-2023) & (K L)
Figure 15. Foot and Mouth Disease Vaccines Consumed in Pig
Figure 16. Global Foot and Mouth Disease Vaccines Market: Pig (2018-2023) & (K L)
Figure 17. Foot and Mouth Disease Vaccines Consumed in Sheep & Goat
Figure 18. Global Foot and Mouth Disease Vaccines Market: Sheep & Goat (2018-2023) & (K L)
Figure 19. Foot and Mouth Disease Vaccines Consumed in Other
Figure 20. Global Foot and Mouth Disease Vaccines Market: Other (2018-2023) & (K L)
Figure 21. Global Foot and Mouth Disease Vaccines Sales Market Share by Application (2022)
Figure 22. Global Foot and Mouth Disease Vaccines Revenue Market Share by Application in 2
Global Classical Swine Fever Vaccines Market Research Report 2024
Published: 08-Jan-2024 Price: US 2900 Onwards Pages: 100
It is a type of vaccine for classical swine fever. Classical swine fever (CSF), also known as hog cholera, is a contagious viral disease of pigs, including wild boar. The causative virus is a member of The genus Pestivirus of The family Flaviviridae, and is closely related to The viruses of bovine viral diarrhoea and border disease. There is only one serotype of CSF virus (CSFV).
The global Classical Swine Fever Vaccines market was valued at US$ 154.7 million in 2023 and is anticipa......
Global Tylosin Market Growth 2024-2030
Published: 04-Jan-2024 Price: US 3660 Onwards Pages: 96
According to our LPI (LP Information) latest study, the global Tylosin market size was valued at US$ 674.4 million in 2023. With growing demand in downstream market, the Tylosin is forecast to a readjusted size of US$ 909 million by 2030 with a CAGR of 4.4% during review period.
The research report highlights the growth potential of the global Tylosin market. Tylosin are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chai......
Global Animal Parasiticides Market Growth 2024-2030
Published: 04-Jan-2024 Price: US 3660 Onwards Pages: 106
According to our LPI (LP Information) latest study, the global Animal Parasiticides market size was valued at US$ 6898.6 million in 2023. With growing demand in downstream market, the Animal Parasiticides is forecast to a readjusted size of US$ 9363.4 million by 2030 with a CAGR of 4.5% during review period.
The research report highlights the growth potential of the global Animal Parasiticides market. Animal Parasiticides are expected to show stable growth in the future market. However, ......
Global Newcastle Disease Vaccine Market Growth 2024-2030
Published: 04-Jan-2024 Price: US 3660 Onwards Pages: 114
According to our LPI (LP Information) latest study, the global Newcastle Disease Vaccine market size was valued at US$ 308 million in 2023. With growing demand in downstream market, the Newcastle Disease Vaccine is forecast to a readjusted size of US$ 389.8 million by 2030 with a CAGR of 3.4% during review period.
The research report highlights the growth potential of the global Newcastle Disease Vaccine market. Newcastle Disease Vaccine are expected to show stable growth in the future m......
Global Classical Swine Fever Vaccines Market Growth 2024-2030
Published: 04-Jan-2024 Price: US 3660 Onwards Pages: 126
According to our LPI (LP Information) latest study, the global Classical Swine Fever Vaccines market size was valued at US$ 151.4 million in 2023. With growing demand in downstream market, the Classical Swine Fever Vaccines is forecast to a readjusted size of US$ 209.8 million by 2030 with a CAGR of 4.8% during review period.
The research report highlights the growth potential of the global Classical Swine Fever Vaccines market. Classical Swine Fever Vaccines are expected to show stable ......
Global Veterinary Vaccine Market Growth 2024-2030
Published: 04-Jan-2024 Price: US 3660 Onwards Pages: 151
According to our LPI (LP Information) latest study, the global Veterinary Vaccine market size was valued at US$ 10570 million in 2023. With growing demand in downstream market, the Veterinary Vaccine is forecast to a readjusted size of US$ 17200 million by 2030 with a CAGR of 7.2% during review period.
The research report highlights the growth potential of the global Veterinary Vaccine market. Veterinary Vaccine are expected to show stable growth in the future market. However, product di......
Global Foot and Mouth Disease (FMD) Vaccines Market Growth 2024-2030
Published: 04-Jan-2024 Price: US 3660 Onwards Pages: 134
According to our LPI (LP Information) latest study, the global Foot and Mouth Disease (FMD) Vaccines market size was valued at US$ 895.6 million in 2023. With growing demand in downstream market, the Foot and Mouth Disease (FMD) Vaccines is forecast to a readjusted size of US$ 1644.2 million by 2030 with a CAGR of 9.1% during review period.
The research report highlights the growth potential of the global Foot and Mouth Disease (FMD) Vaccines market. Foot and Mouth Disease (FMD) Vaccines......
Global Veterinary Products for Companion Animals Market Growth 2024-2030
Published: 04-Jan-2024 Price: US 3660 Onwards Pages: 109
According to our LPI (LP Information) latest study, the global Veterinary Products for Companion Animals market size was valued at US$ 15190 million in 2023. With growing demand in downstream market, the Veterinary Products for Companion Animals is forecast to a readjusted size of US$ 22710 million by 2030 with a CAGR of 5.9% during review period.
The research report highlights the growth potential of the global Veterinary Products for Companion Animals market. Veterinary Products for Co......
Global Newcastle Disease Vaccine Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
Published: 01-Jan-2024 Price: US 3480 Onwards Pages: 115
According to our (Global Info Research) latest study, the global Newcastle Disease Vaccine market size was valued at USD 323.9 million in 2023 and is forecast to a readjusted size of USD 402.7 million by 2030 with a CAGR of 3.2% during review period.
Newcastle disease is a contagious viral bird disease affecting many domestic and wild avian species; it is transmissible to humans.
Newcastle disease can be controlled by the use of vaccines. There are many Newcastle disease vaccines s......
SERVICES
Value for Money
We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
Ever Growing Inventory
Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
One Stop Solution
Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
Dedicated Client Engagement
Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
Saving Time and Efforts
Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
Payment Flexibility
Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
Post-Purchase Research Support
Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements.
Subscription Offers & Packages (Get in touch with us for more details -
[email protected] / +1 888 391 5441 )
- Ad Hoc
-
- Pay - as - you - go / Bucket Subscriptions
- Fixed Cost for #of reports
- Customize / Personalize as per your needs
